VPC-8 series

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameVPC-8 series
Drug Alias Nameautotaxin inhibitors (Catena Pharmaceuticals)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionEctonucleotide pyrophosphatase/phosphodiesterase 2 inhibitors
TargetsEctonucleotide pyrophosphatase/phosphodiesterase 2
Therapy Area/IndicationsFibrosisNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCatena Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCatena Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsFibrosisNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A